Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04977453
Brief Title: GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors

First Submitted : July 9, 2021
First Submitted that Met QC Criteria : July 26, 2021
First Posted : July 27, 2021

Last Update Submitted that Met QC Criteria : August 3, 2021
Last Update Posted : August 4, 2021